Rezolute Announces Appointment of Congenital Hyperinsulinism Therapeutic Area Expert, Dr. Christine Ferrara, as Director of Clinical Development
Stock Information for Rezolute Inc.
Loading
Please wait while we load your information from QuoteMedia.